|
|
|
|
LEADER |
00000nam a2200000 a 4500 |
001 |
3731519 |
003 |
ICU |
005 |
20030527172900.0 |
008 |
980528s1999 njua b 001 0 eng c |
010 |
|
|
|a 98027244
|
020 |
|
|
|a 0896033694 (alk. paper)
|
035 |
|
|
|a (NhCcYBP)YBT 98027244
|
035 |
|
|
|a (NhCcYBP)YBP40003251697
|
040 |
|
|
|a DNLM/DLC
|c DLC
|d DLC
|d OrLoB-B
|d OCoLC
|
050 |
0 |
0 |
|a QR201.A37
|b H56 1999
|
060 |
1 |
0 |
|a WC 503.6
|b H6765 1998
|
082 |
0 |
0 |
|a 616.97/92
|2 21
|
245 |
0 |
0 |
|a HIV protocols /
|c edited by Nelson L. Michael and Jerome H. Kim.
|
260 |
|
|
|a Totowa, N.J. :
|a Humana Press,
|c c1999.
|
300 |
|
|
|a xiii, 421 p. :
|b ill. ;
|c 24 cm.
|
336 |
|
|
|a text
|b txt
|2 rdacontent
|0 http://id.loc.gov/vocabulary/contentTypes/txt
|
337 |
|
|
|a unmediated
|b n
|2 rdamedia
|0 http://id.loc.gov/vocabulary/mediaTypes/n
|
338 |
|
|
|a volume
|b nc
|2 rdacarrier
|0 http://id.loc.gov/vocabulary/carriers/nc
|
440 |
|
0 |
|a Methods in molecular medicine
|v 17
|
500 |
|
|
|a Includes index
|
505 |
0 |
0 |
|g Pt. I.
|t Virology.
|g 1.
|t Isolation and Expansion of HIV from Cells and Body Fluids by Coculture /
|r James R. Lane.
|g 2.
|t Quantitative HIV Culture /
|r James R. Lane.
|g 3.
|t Quantitation of Cell-Free HIV by Reverse Transcriptase Activity /
|r James R. Lane.
|g 4.
|t Determination of Syncytium-Inducing Phenotype of Primary HIV-1 Isolates Using MT-2 Cells /
|r Mark K. Louder and John R. Mascola.
|g 5.
|t Determination of HIV-1 Chemokine Coreceptor Tropism Using Transduced Human Osteosarcoma (HOS) Cells /
|r Mark K. Louder and John R. Mascola.
|g 6.
|t Use of Luciferase Reporter Viruses for Studying HIV Entry /
|r Rong Liu, Benjamin Chen and Nathaniel R. Landau.
|g 7.
|t A Cell-Cell Fusion Assay to Monitor HIV-1 Env Interactions with Chemokine Receptors /
|r Almee L. Edinger and Robert W. Doms.
|g 8.
|t Methods of Culturing HIV-1 from Semen /
|r Bruce L. Gilliam --
|g Pt. II.
|t Molecular Biology.
|g 9.
|t Detection of HIV-1 Nucleic Acids by Southern Blotting /
|r Richard A. McDonald.
|g 10.
|t Detection of HIV-1 Nucleic Acids by Northern Blotting /
|r Richard A. McDonald and Christopher A. D. Smith.
|g 11.
|t Rapid Identification of Cloned HIV-1 Fragments /
|r Wei Dong, Anindita Kar Roy and Yen Li.
|g 12.
|t PCR Amplification and Cloning of Virtually Full-Length HIV-1 Provirus /
|r Mika Salminen.
|g 13.
|t Quantitation of HIV-1 gag DNA and RNA From Single Frozen Cell Pellets /
|r Maryanne Vahey, Sandra C. Barrick and Martin Nau.
|g 14.
|t Quantitative PCR for HIV-1 Proviral DNA /
|r Davide Zella and Paola Secchiero.
|g 15.
|t Diagnosis and Direct Automated Sequencing of HIV-1 From Dried Blood Spots (DBS) Collected on Filter Paper /
|r Sharon A. Cassol, Stanley Read and Bruce G. Weniger [et al.].
|g 16.
|t Quantification of HIV-1 RNA in Dried Plasma Spots (DPS): A Field Approach to Therapeutic Monitoring /
|r Sharon A. Cassol, Francisco Diaz-Miltoma and Richard Pilon [et al.].
|g 17.
|t Quantitation of HIV-1 RNA in Genital Secretions /
|r Bruce L. Gilliam.
|g 18.
|t Detection of Nucleic Acids in Cells and Tissues by In Situ Polymerase Chain Reaction /
|r Omar Bagasra, Lisa E. Bobroski and Mohammad Amjad [et al.].
|g 19.
|t Determination of the Promoter Activity of HIV-1 Using the Chloramphenicol Acetyltransferase Reporter Gene Assay /
|r Loretta Tse and Nelson L. Michael.
|g 20.
|t In Vitro Techniques for Studies of HIV-1 Promoter Activity /
|r Fabio Romerio and David M. Margolis.
|g 21.
|t Detection of Polymorphisms in the HIV-1 Coreceptor CCR5 Using Single-Strand Conformation Polymorphism /
|r Maureen P. Martin and Mary Carrington.
|g 22.
|t Sequence-Specific Priming as a Rapid Screen for Known Mutations /
|r Mary Carrington.
|g 23.
|t Quantitation of HIV-1 Entry Cofactor Expression /
|r James L. Riley and Richard G. Carroll.
|g 24.
|t Retrovirus-Mediated Gene Transduction of SupT1 Cells /
|r Jen-Tsun J. Lin and Jerome H. Kim.
|g 25.
|t Cloning of HIV Single-Strand DNA Binding Protein from Human Lymphocyte Lambda gt11 Expression Library with [[superscript 32]P]-Oligomers /
|r Sook-Jin Hur and Derhsing Lai.
|g 26.
|t Telomeric Terminal Restriction Fragment (TRF) /
|r Sumesh Kaushal --
|g Pt. III.
|t Humoral Immunology.
|g 27.
|t Serologic Analysis by Enzyme-Linked Immunosorbent Assay (ELISA) /
|r Melissa Krider and Lawrence D. Loomis-Price.
|g 28.
|t Quantitative Immunoblotting with Fusion Proteins /
|r Margaret M. Mitchell and Lawrence D. Loomis-Price.
|g 29.
|t Analysis of Antibody Interactions with HIV-1 Envelope Expressed on the Surface of Acutely Infected H9 Cells /
|r Thomas C. VanCott and Paul L. Hallberg.
|g 30.
|t Analysis of Antibody-Antigen Interactions Using Surface Plasmon Resonance /
|r Thomas C. VanCott.
|g 31.
|t Measurement of HIV-1 Specific and Total Antibody Secreting Cells by ELISPOT /
|r Frederik W. van Ginkel, John L. VanCott and Robert Kaminski [et al.].
|g 32.
|t Linear Epitope Mapping by the PEPSCAN Method /
|r Lawrence D. Loomis-Price.
|g 33.
|t Neutralization of HIV-1 Infection of Human Peripheral Blood Mononuclear Cells (PBMC): Antibody Dilution Method /
|r John R. Mascola.
|g 34.
|t Neutralization of HIV-1 Infection of Human Peripheral Blood Mononuclear Cells (PBMC): Infectivity Reduction Method /
|r John R. Mascola.
|g 35.
|t Collection and Processing of Mucosal Secretions from HIV-1 Infected Women /
|r Andrew W. Artenstein and Thomas C. VanCott.
|g 36.
|t Collection and Processing of Mucosal Secretions from Mice /
|r Robert W. Kaminski and Thomas C. VanCott --
|g Pt. IV.
|t Cellular Immunology.
|g 37.
|t Lymphocyte Proliferation Assay /
|r Karl V. Sitz and Deborah L. Birx.
|g 38.
|t HIV-1 Specific Cytotoxic T-Cell Assays /
|r Josephine H. Cox.
|g 39.
|t HIV-1 Specific Antibody-Dependent Cellular Cytotoxicity (ADCC) /
|r Josephine H. Cox.
|g 40.
|t Evaluation of Natural Killer Cell Activity /
|r Josephine H. Cox.
|g 41.
|t Generation and Expansion of HIV-1 CD4+ Antigen-Specific T Cell Lines /
|r Silvia Ratto-Kim.
|g 42.
|t Immunophenotyping and Assessment of Cell Function by Three-Color Flow Cytometry of Peripheral Blood Lymphocytes /
|r Stephen P. Perfetto and Gilbert McCrary.
|g 43.
|t Detection of Apoptosis in HIV-Infected Cell Populations using TUNEL /
|r Patrick J. Blair and Stephen P. Perfetto.
|
650 |
|
0 |
|a AIDS (Disease)
|v Laboratory manuals.
|
650 |
|
0 |
|a HIV (Viruses)
|v Laboratory manuals.
|
650 |
|
0 |
|a HIV infections
|v Laboratory manuals.
|
650 |
1 |
2 |
|a HIV Infections
|x prevention & control.
|
650 |
1 |
2 |
|a Clinical Protocols.
|
650 |
2 |
2 |
|a Molecular Biology
|x methods.
|
650 |
2 |
2 |
|a Immunologic Techniques.
|
650 |
2 |
2 |
|a Virology
|x methods.
|
650 |
|
7 |
|a AIDS (Disease)
|2 fast
|0 http://id.worldcat.org/fast/fst00793808
|
650 |
|
7 |
|a HIV infections.
|2 fast
|0 http://id.worldcat.org/fast/fst00949871
|
650 |
|
7 |
|a HIV (Viruses)
|2 fast
|0 http://id.worldcat.org/fast/fst00949837
|
655 |
|
7 |
|a Laboratory manuals.
|2 fast
|0 http://id.worldcat.org/fast/fst01920776
|
700 |
1 |
|
|a Michael, Nelson.
|0 http://id.loc.gov/authorities/names/n98801700
|1 http://viaf.org/viaf/39551076
|
700 |
1 |
|
|a Kim, Jerome H.
|0 http://id.loc.gov/authorities/names/n86824515
|1 http://viaf.org/viaf/71567154
|
901 |
|
|
|a ToCBNA
|
903 |
|
|
|a HeVa
|
903 |
|
|
|a Hathi
|
035 |
|
|
|a (OCoLC)39236401
|
929 |
|
|
|a cat
|
999 |
f |
f |
|i 2f0a3a38-5389-50d1-a26b-565ad4a75d31
|s bbd5feaf-0b30-588d-897a-f23665e40016
|
928 |
|
|
|t Library of Congress classification
|a QR201.A37 H56 1999
|l JCL
|c JCL-Sci
|i 4085194
|
927 |
|
|
|t Library of Congress classification
|a QR201.A37 H56 1999
|l JCL
|c JCL-Sci
|e CRERAR
|b 50242603
|i 6159433
|